A new treatment for those suffering from "chronic" eczema is set to be available on the NHS within the next three months.
More than 62,000 people in England with debilitating hand eczema could benefit from a new treatment that has been given the ...
Nearly 1 in 10 U.S. adults report having physician-diagnosed chronic head eczema, according to findings from a ...
More than 31 million people in the U.S. live with eczema, a chronic skin condition that can disrupt daily life yet continues ...
The National Institute for Health and Care Excellence (NICE) has approved the first-and-only topical treatment of its kind in adults with moderate to severe Chronic Hand Eczema (CHE) when topical ...
San Diego — Data from an open-label extension study of delgocitinib cream reflects the positive phase 3 safety and efficacy results released > 1 year ago from two separate trials in patients with ...
If you’ve ever experienced eczema, or you know someone who has, you’re probably familiar with the physical effects of itchy, irritated skin. But the chronic condition can take a major mental toll, too ...
The National Institute for Health and Care Excellence (Nice) has recommended that the cream should be offered to people with ...
Delgocitinib, also known as Anzupgo, has been given the green light for NHS use for adults with moderate to severe chronic hand eczema. More than 62,000 people in England with debilitating hand eczema ...
The mom and daughter have found a non-steroidal solution that's helped managed both chronic and episodic eczema ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results